Design Therapeutics Inc. (DSGN)
undefined
undefined%
At close: undefined
5.60
0.54%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - 226.00 834.00
Cost of Revenue 537.00K 466.00K 129.00K 5.00K 1.65K
Gross Profit -537.00K -466.00K -129.00K -4.77K -820
Operating Income -78.19M -67.59M -35.83M -8.33M -1.91M
Interest Income - - - - -
Pretax Income -66.86M -63.31M -35.53M -8.28M -2.05M
Net Income -66.86M -58.62M -35.53M -8.28M -2.05M
Selling & General & Admin 21.13M 18.98M 11.05M 2.50M 1.09M
Research & Development 57.06M 48.61M 24.78M 6.06M 1.65M
Other Expenses - 4.29M 298.00K -226.00K -834.00K
Operating Expenses 78.19M 67.59M 35.83M 8.33M 1.91M
Interest Expense - - - - -
Selling & Marketing Expenses - - - - -
Cost & Expenses 78.19M 67.59M 35.83M 8.33M 1.91M
Income Tax -1 -4.69M -107.56K -201.30K -1.91K
Shares Outstanding (Basic) 55.98M 55.71M 45.94M 27.19M 27.19M
Shares Outstanding (Diluted) 55.98M 55.71M 45.94M 27.19M 27.19M
EPS (Basic) -1.19 -1.05 -0.77 -0.3 -0.08
EPS (Diluted) -1.19 -1.05 -0.77 -0.3 -0.08
EBITDA -66.33M -62.84M -35.70M -8.32M -139.00K
Depreciation & Amortization 537.00K 466.00K 129.00K 5.00K 1.91M